Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Teva Pharmaceutical Industries Ltd. > News item |
Emerging markets quiet; funds see $851 million of inflows; China Development prices add-on
By Aleesia Forni
Columbus, Ohio, March 23 - Emerging markets saw a quiet session on Friday, according to one market source.
Cash continued to flow into emerging markets bond funds, which saw $851 million of inflows for the week, according to a figure provided by fund-tracker EPFR Global. This was less than last week's $1.43 billion.
The latest week's flow increases year-to-date inflows to $4.12 billion, according to a Prospect News analysis of the data.
This marks emerging markets bond funds' best start to a year on record, according to information released by EPFR Global.
The Markit iTraxx SovX CEEMEA index, which tracks Central and Eastern Europe, the Middle East and Africa credit-default swaps, traded at 270 basis points during the Friday London session, 16 bps tighter on the week.
In the primary market, China Development Bank Corp. priced an add-on, while Teva Pharmaceutical Industries Ltd. is planning an offering of senior notes.
China Development add-on
China Development Bank (Aa3/AA-/A+) priced a RMB 1 billion add-on to its existing 4.2% offshore bonds, according to a buyside source.
Barclays Capital is the bookrunner.
Proceeds will be used to fund renminbi-denominated loans, for working capital and for general corporate purposes.
China Development Bank is a financial institution based in Beijing.
Teva Pharmaceutical offer
Teva Pharmaceutical intends to offer euro- and Swiss franc-denominated senior notes, according to a 6-K filing with the Securities and Exchange Commission.
The Petach Tikva, Israel-based pharmaceutical company intends to use proceeds from the anticipated Regulation S offering to refinance maturing debt.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.